Skip to main content
Smart Investors Daily
McKesson Corporation logo

NYSE · MCK

McKesson Corporation

Healthcare · Medical - Distribution

$1,084.43

Down-$22.27 (-2.05%)

Updated Nov 20, 2026, 1:19 AM

SID Score

7.3/10

Composite research score

Smart Money

57/100

Neutral

Market cap
101.96B
P/E ratio
32.2
Dividend yield
0.28%
52-week range
$723.68 – $1,121.50
Volume
674.53K
Avg. volume
896.08K

Price performance · MCK

MCK price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

MCK closed at $1,084.43 after 20 trading sessions, up 7.12% for the selected period.

Last close
$1,084.43
Period change
+7.12%
Period low
$960.56
Period high
$1,105.04
Daily close
View OHLC price history
MCK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$1,083.34$1,092.30$1,073.12$1,084.43674.53K
Nov 17, 2026$1,092.86$1,109.37$1,085.17$1,091.67722.82K
Nov 16, 2026$1,117.98$1,118.01$1,099.70$1,105.04900.06K
Nov 13, 2026$1,087.46$1,104.32$1,083.54$1,102.81527.49K
Nov 12, 2026$1,090.00$1,090.898$1,074.65$1,077.05539K
Nov 11, 2026$1,075.23$1,081.4725$1,067.375$1,079.79474.9K
Nov 10, 2026$1,064.42$1,086.94$1,059.00$1,082.59605.2K
Nov 9, 2026$1,067.49$1,069.11$1,055.73$1,059.37490.69K
Nov 6, 2026$1,051.67$1,070.145$1,046.70$1,060.84812.14K
Nov 5, 2026$1,085.84$1,121.50$1,072.00$1,072.001.29M
Nov 4, 2026$1,020.00$1,073.95$1,004.88$1,069.441.17M
Nov 3, 2026$990.89$1,009.36$983.6201$999.62691.21K
Nov 2, 2026$995.61$1,008.65$990.3005$998.38720.28K
Oct 30, 2026$1,006.29$1,016.92$990.2959$994.58763.21K
Oct 29, 2026$975.00$982.70$964.77$980.88721.49K
Oct 28, 2026$955.95$970.925$954.05$960.56764.14K
Oct 27, 2026$989.04$992.8225$966.49$967.02587.07K
Oct 26, 2026$1,001.39$1,008.60$988.03$992.87508.22K
Oct 23, 2026$1,010.32$1,012.495$997.02$1,000.77628.97K
Oct 22, 2026$1,025.62$1,025.62$1,006.07$1,012.34629.49K

Latest MCK news

The latest Smart Investors Daily articles mentioning MCK.

MCK research

Overview

Company profile and research snapshot.

Company profile

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$910.40
Implied upside
—
Analysts
12
MCK recent ratings
DateFirmRatingTarget
Nov 18, 2026BarclaysOverweight—
Nov 10, 2026JP MorganOverweight—
Nov 5, 2026Evercore ISI GroupOutperform—
Nov 5, 2026UBSBuy—
Nov 5, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.